A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/1992
11/12/1992	WO1992020060A1 Electrophoretic display panel with tapered grid insulators and associated methods
11/12/1992	WO1992019595A1 Fibrinogen receptor antagonists
11/12/1992	WO1992019252A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992	CA2107915A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992	CA2102508A1 Electrophoretic display panel with tapered grid insulators and associated methods
11/12/1992	CA2068263A1 Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
11/11/1992	EP0512831A1 Fibrinogen receptor antagonists
11/11/1992	EP0512829A1 Fibrinogen receptor antagonists
11/11/1992	CN1066065A Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
11/10/1992	WO1992019279A1 Phospholipid-targeted thrombolytic agents
11/10/1992	US5162359 Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2-thion derivatives
11/10/1992	US5162350 Benzothiazolinone compounds
11/10/1992	CA2086437A1 Phospholipid-targeted thrombolytic agents
11/10/1992	CA1310011C 1,4-dihydropyridine derivatives having a nitrogen containing heteroaryl group linked to the two position possessing antihypertensive and antithrombotic activity
11/08/1992	CA2068054A1 Fibrinogen receptor antagonists
11/04/1992	EP0511932A2 Process for the obtaining of polymers with activity on the hematopoietic system
11/04/1992	EP0511234A1 Stable injectible solutions for factor viii.
11/04/1992	CN1065865A Indole and dihydroquinoline potassium channel openers
11/04/1992	CN1018924B Process for preparing copolymers of vinyl alcohol with embedded glutaric aldehyde and vinyl acetic-ester
11/03/1992	WO1992019594A1 Pyrrolidinones
11/03/1992	US5160725 Magnetic liquid compositions
11/03/1992	CA2102106A1 Pyrrolidinones
11/03/1992	CA1309718C 5-(6-imidazo[1,2-a]pyridyl)pyridine derivative
10/1992
10/29/1992	WO1992018544A1 Sulfate polysaccharides, preparation method, pharmaceutical composition and utilization
10/29/1992	WO1992018157A1 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration
10/29/1992	WO1992018136A1 Blood substitutes and organ preservative solutions
10/29/1992	WO1992015607A3 Phenyl amidines derivatives useful as platelet aggregation inhibitors
10/29/1992	DE4200954A1 New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
10/29/1992	CA2108363A1 Sulphated polysaccharides, process for their preparation, pharmaceutical composition and utilization
10/28/1992	EP0511075A1 Sulfated polysaccharides, process for their preparation, pharmaceutical composition and use thereof
10/28/1992	EP0511073A1 Antiserotonines, their preparation and medicaments containing them
10/28/1992	EP0510662A1 bFGF mutein and its production
10/28/1992	EP0510398A2 N-Imidazolyl derivatives of substituted indole
10/28/1992	EP0510082A1 Oxidized variants of gm-csf
10/27/1992	WO1992019624A1 Antiserotonines, prepartion thereof and medicaments containing them
10/27/1992	US5159061 Hypotensive agent, diuretic
10/27/1992	US5158967 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
10/27/1992	CA2103562A1 Antiserotonins, preparation thereof and medicaments containing them
10/27/1992	CA2066931A1 Bfgf mutein and its production
10/27/1992	CA1309414C Cycloalkano[1,2-b]indole-sulphonamides
10/27/1992	CA1309402C Heparin derivatives and process for their preparation
10/25/1992	CA2066938A1 N-imidazolyl derivatives of substituted indole
10/23/1992	WO1992018163A1 Medicine for intraocular operation
10/23/1992	CA2085732A1 Pharmaceutical composition for use in intraocular surgery
10/21/1992	EP0509845A1 (+) and (-) enantiomers of 5-aliphatic-6-(benzoxazinyl- or benzothiazinyl)-2,3,4,5-tetrahydropyridazin-3-ones
10/21/1992	EP0509795A2 Carbamates of rapamycin
10/21/1992	EP0509762A1 Indole and dihydroquinoline potassium channel openers
10/21/1992	EP0509088A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
10/21/1992	EP0509080A1 Inhibitors and substrates of thrombin
10/21/1992	EP0509054A1 Preparation of fibrinogen/factor xiii precipitate
10/21/1992	EP0509041A1 Fibrin sealant delivery method
10/21/1992	EP0373213B1 Utilization of a folinic substance as platelet antiaggregating agent
10/20/1992	US5157140 Esters of myo-inositol phosphate
10/20/1992	US5157042 3-oxa-5-fluoro-carbacyclins, their preparation and use as medicinal agents
10/20/1992	US5156969 Treating vascular disorders
10/20/1992	US5156967 Treatment with ion exchange resin
10/20/1992	CA1309098C Dihydropyridine derivatives, their preparation and their use
10/20/1992	CA1309095C Aminoimidazoquinoline derivatives
10/20/1992	CA1309087C Cyclodextrin clathrates of carbacyclin derivatives and their use as medicinal agents
10/19/1992	CA2066311A1 (+) and (-) enantiomers of 5-aliphatic-6-(benzoxazinyl- or benzothiazinyl)-2,3,4,5-tetrahydropyridazin-3-ones
10/16/1992	CA2065499A1 Indole and dihydroquinoline potassium channel openers
10/15/1992	WO1992017500A1 Novel megakaryocyte amplifying factor and production thereof
10/15/1992	WO1992017178A1 Remedy for thrombosis and phosphodiesterase inhibitor
10/15/1992	WO1992017065A2 Method of inhibiting fibrosis
10/15/1992	CA2107371A1 Method of inhibiting fibrosis
10/14/1992	EP0508687A1 ATP analogues
10/14/1992	EP0508549A2 New triazolopyrimidine and pyrazolopyrimidine derivatives useful for treating cachexia
10/14/1992	EP0508220A1 Derivatives of amindinophenylalanine, procedure for their preparation, their utilisation and compositions comprising them
10/14/1992	EP0508194A1 Stabilized factor VIII preparations
10/14/1992	EP0507870A1 Polyhemoglobin stabilized by purine derivatives and glutathione.
10/14/1992	EP0507850A1 Determining the diuretic potency of candidate drugs
10/13/1992	US5155121 Phenylsulphonamide substituted pyridinealkene- and aminooxyalkanecarboxylic acid derivatives
10/13/1992	US5155103 Methods of using new thieno-triazole-1,4-diazepino-2-carboxylic acid amides
10/13/1992	US5154921 Removing cells from animal, contacting with polypeptide growth factor, GRO
10/13/1992	CA2065689A1 Pharmaceutical composition and process for the preparation thereof
10/13/1992	CA1308864C Serine protease inhibitors
10/13/1992	CA1308660C Pharmaceutical compositions containing 1,3-dioxane alkenoic acid derivatives
10/12/1992	WO1992018117A1 Anti-thrombotic peptide and pseudopeptide derivatives
10/11/1992	WO1992018002A1 Nitrosation of homocysteine as a method for treating homocysteinemia
10/11/1992	CA2108152A1 Nitrosation of homocysteine as a method for treating homocysteinemia
10/10/1992	CA2065585A1 Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them
10/07/1992	WO1992017488A1 Atp analogues
10/07/1992	EP0507187A1 Method for inhibiting pulmonary oxygen toxicity
10/07/1992	EP0506821A1 Hybrid protein c
10/07/1992	EP0506757A1 A recombinant human factor viii derivative
10/07/1992	EP0493380A4 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/07/1992	CA2107667A1 Atp analogues
10/06/1992	WO1992017492A1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIII¿a?
10/06/1992	US5153214 Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
10/06/1992	US5153190 Pyrrolo [1,2A] thieno [3,2-F] [1,4] diazepines
10/06/1992	US5153176 Substituted lysine-proline-arginine peptide
10/06/1992	US5152979 Method for treating vascular obstructions caused by abnormal cells
10/06/1992	CA2106314A1 Platelet aggregation inhibitors having high specification for gpiibiiia
10/06/1992	CA1308413C Pyridazinone derivatives
10/06/1992	CA1308377C Complex of polyethyleneglycol and tissue plasminogen activator
10/05/1992	WO1992017451A1 Pyridine- and imidazole-derived agents for cardiovascular diseases
10/05/1992	WO1992017203A1 Enzymatic neutralization of heparin
10/01/1992	WO1992016557A1 Recombinant human factor viii derivatives
10/01/1992	WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
10/01/1992	WO1992016484A1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity

1 ... 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 ... 671